Personalis, Duke University, Olink Collaborate on Immunother

They plan to study the genomic, transcriptomic, and proteomic responses of gastroesophageal tumors following treatment with Merck's Keytruda.

Related Keywords

Marijana Rucevic , Andrew Nixon , Duke University School Of Medicine , Phasei Biomarker Laboratory , Duke University , Olink Proteomics , Menlo Park , California Based Personalis , Duke University School , Sweden Based Olink ,